Ad Scientiam winner of the French Healthcare Booster Germany 2023!

Ad Scientiam was selected by a jury of French and German experts made up of specialists from the German medtech market, the pharmaceutical industry, digital specialists and Bpifrance. This program will support Ad Scientiam in the development of its activities in Germany.

Share

Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases Read the article
en_USEnglish